---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275047686.md"
description: "The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Pharma fell by 15.21%, Sionna Therapeutics decreased by 15.12%, Abcellera Biologics declined by 14.98%, and Editas Medicine fell by 14.62%. Gilead Sciences rose by 2.15%, Silence Therapeutics increased by 5.12%, Erasca went up by 5.69%, and Phibro Animal Health surged by 22.02%"
datetime: "2026-02-05T23:56:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275047686.md)
  - [en](https://longbridge.com/en/news/275047686.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275047686.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index fell by 2%, with component stock Jyong Biotech down 20.95%, BridgeBio Pharma down 15.21%, Sionna Therapeutics down 15.12%, Abcellera Biologics down 14.98%, and Editas Medicine down 14.62%. Gilead Sciences, on the other hand, rose by 2.15%, with Silence Therapeutics up 5.12%, Erasca up 5.69%, and Phibro Animal Health up 22.02%

### Related Stocks

- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [EDIT.US](https://longbridge.com/en/quote/EDIT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBIO.US](https://longbridge.com/en/quote/BBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)
- [MENS.US](https://longbridge.com/en/quote/MENS.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ABCL.US](https://longbridge.com/en/quote/ABCL.US.md)
- [SION.US](https://longbridge.com/en/quote/SION.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SLN.US](https://longbridge.com/en/quote/SLN.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [BBIO: Attruby's clinical edge and new launches drive growth, targeting profitability by 2027](https://longbridge.com/en/news/299073915.md)
- [Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stock](https://longbridge.com/en/news/299231462.md)
- [GILD: Strong HIV growth, new launches, and oncology advances drive portfolio momentum](https://longbridge.com/en/news/299078477.md)
- [Should Gilead Sciences (GILD) Reconsider Its Global HIV Case After This PAHO Deal?](https://longbridge.com/en/news/299152634.md)
- [Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF](https://longbridge.com/en/news/299371505.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**